PAPER Kliushnik TP, Androsova LV, Mikhaylova NM, Kolykhalov IV, Zozulya SA, Dupin AM
SEARCH RESULTS
229120 RESULTS
PAPER Kovrazhkina EA, Razinskaya OD, Gubsky LV
[Clinical polymorphism of amyotrophic lateral sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(8):4-10. PubMed.PAPER Mikhaylova NM
[Organization of out-patient psychiatric care in dementia and cognitive impairment. Part I: Memory clinics and Alzheimer's disease centers].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):111-119. PubMed.PAPER Mikhaylova NM
[Organization of out-patient psychiatric care in dementia and cognitive impairment in aged. Part II: Clinical and economic efficacy of memory clinics and Alzheimer's disease centers].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(7):89-98. PubMed.PAPER Senkevich KA, Miliukhina IV, Beletskaia MV, Gracheva EV, Kudrevatykh AV, Nikolaev MA, Emelyanov AK, Kopytova AE, Timofeeva AA, Yakimovskii AF, Pchelina SN
[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):81-86. PubMed.PAPER Zakharov VV, Gromova DO
[Current approaches to management of patients with mild cognitive impairment].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3):107-112. PubMed.PAPER Levitsky GN, Chub RV, Kryachkov AV
[The quality of medical care and cooperation of patients with amyotrophic lateral sclerosis in the Russian Federation].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(1. Vyp. 2):59-63. PubMed.PAPER Maltsev AV, Deykin AV, Ovchinnikov RK, Chicheva MM, Kovrazhkina EA, Razinskaya OD, Bronovitsky EV, Budevich AI, Kirikovich YK, Bachurin SO, Ustyugov AA, Skvortsova VI
[Dimebon delays the onset of symptoms of FUS-proteinopathy in transgenic mice].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(4):64-67. PubMed.PAPER Moroz AA, Abramycheva NY, Stepanova MS, Konovalov RN, Timerbaeva SL, Illarioshkin SN
[Differential diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(4):75-80. PubMed.PAPER Chebotareva AD, Levin OS, Markov DD, Sychev DA, Grishina EA
[Is it personalized treatment of dementia based on the CYP2D6 gene polymorphism possible?]
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):90-94. PubMed.PAPER Ekimova IV, Gazizova AR, Karpenko MN, Plaksina DV
[Signs of anhedonia and destructive changes in the ventral tegmental area of the midbrain in the model of the preclinical Parkinson's disease stage in experiment].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(9):61-67. PubMed.PAPER Gavrilova SI, Kolykhalov IV, Ponomareva EV, Fedorova YB, Selezneva ND
[Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(5):45-53. PubMed.PAPER Kiskis J, Horvath I, Wittung-Stafshede P, Rocha S
[The processes of α-synuclein amyloid protein complexes involved in the pathogenesis of Parkinson's disease].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8):75-81. PubMed.PAPER Levin OS, Vasenina EE, Sonin AG, Tayupova GN, Zatsepina OE, Ostapenko TN
[The feasibility of using Quick Dementia Rating System in clinical practice: results of a multi-center prospective validation study].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(10):40-47. PubMed.PAPER Litvinenko IV, Dynin PS, Trufanov AG, Gimadutdinov RF, Maltsev DS
[Eye as an object of investigation of cognitive impairment in Parkinson's disease].
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):105-114. PubMed.Current Filters
- TYPE: Paper x